Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 3Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Genitourinary 4Other 1Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Prostatic Neoplasms 4Breast Neoplasms 4Melanoma 2Urinary Bladder Neoplasms 1Spondylitis, Ankylosing 1Skin Carcinoma 1Rectal Neoplasms 1Pyloric Stenosis, Hypertrophic 1Psoriasis 1Pancreatic Neoplasms 1Overweight 1Ovarian Neoplasms 1Obesity-Related Malignant Neoplasm 1Obesity 1Neoplasm Metastasis 1Malignant Solid Neoplasm 1Malignant Female Reproductive System Neoplasm 1Lymphedema 1Lupus Erythematosus, Systemic 1Lung Neoplasms 1Kidney Neoplasms 1Inflammatory Bowel Diseases 1Hematopoietic and Lymphatic System Neoplasm 1Hematologic Neoplasms 1Endometrial Neoplasms 1Crohn Disease 1Colorectal Neoplasms 1Colonic Neoplasms 1Colitis, Ulcerative 1Clinical Stage I Esophageal Adenocarcinoma American Joint Committee on Cancer (AJCC) v8 1

Interventions

Magnetic Resonance Spectroscopy 28enzalutamide 23Specimen Handling 20apalutamide 17Androgen Antagonists 14Radiosurgery 13Radiotherapy 12Prednisone 12Docetaxel 12Abiraterone Acetate 12abiraterone 10Biopsy 10Radiation 8niraparib 6luprolide acetate gel depot 6darolutamide 6Pluvicto 6Leuprolide 62-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 6relugolix 5gallium 68 PSMA-11 5cabazitaxel 5acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 5Nivolumab 5Gonadotropin-Releasing Hormone 5bicalutamide 4Triptorelin Pamoate 4Surveys and Questionnaires 4Radiotherapy, Intensity-Modulated 4Glutamate Carboxypeptidase II 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Early Intervention, Educational × 30 days × Clear all
NCT05056077 2026-05-18

TTBF

University of California, San Francisco

Phase NA Active not recruiting
353 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

NCT05627219 2026-05-15

Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network

Thomas Jefferson University

Recruiting
30 enrolled
Genitourinary

Prostatic Neoplasms

NCT06011499 2026-05-08

iLIVE

OHSU Knight Cancer Institute

Phase NA Recruiting
250 enrolled
Genitourinary

Prostatic Neoplasms

NCT03880422 2026-05-07

Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate Cancer

Roswell Park Cancer Institute

Phase NA Recruiting
50 enrolled
GenitourinaryOther

Obesity, Prostatic Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡